What are the symptoms and treatment of Kawasaki syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms and Treatment of Kawasaki Disease

Kawasaki disease is an acute, self-limited vasculitis of childhood characterized by fever lasting at least 5 days, plus four of five principal clinical features: bilateral non-exudative conjunctivitis, oral mucosal changes, polymorphous rash, extremity changes, and cervical lymphadenopathy, with treatment consisting of intravenous immunoglobulin (IVIG) and aspirin to prevent coronary artery complications. 1, 2

Principal Diagnostic Criteria

  • Fever: Typically high-spiking (>39°C to 40°C), persisting for at least 5 days if untreated 3
  • Bilateral bulbar conjunctival injection: Non-exudative, without exudate, often sparing the limbus 3
  • Changes in lips and oral cavity: Erythema and cracking of lips, strawberry tongue, diffuse injection of oral and pharyngeal mucosae 3
  • Polymorphous exanthema/rash: Most commonly diffuse maculopapular eruption, but can also be scarlatiniform, erythema multiforme-like, or urticarial 3, 1
  • Changes in extremities: Acute phase - erythema and edema of hands and feet; subacute phase - periungual desquamation (peeling) beginning 2-3 weeks after fever onset 3, 1
  • Cervical lymphadenopathy: Usually unilateral, ≥1.5 cm in diameter, least common of the principal features 3

Other Clinical and Laboratory Findings

  • Cardiovascular: Gallop rhythm, distant heart sounds, ECG changes, cardiomegaly, pericardial effusion, coronary aneurysms 3
  • Gastrointestinal: Diarrhea, vomiting, abdominal pain, hydrops of gallbladder, mild jaundice 3, 1
  • Blood: Elevated ESR, leukocytosis with left shift, positive CRP, hypoalbuminemia, mild anemia 3, 1
  • Urinary: Sterile pyuria 1, 4

Diagnosis of Incomplete Kawasaki Disease

  • Consider incomplete Kawasaki disease in children with fever ≥5 days and only 2-3 principal clinical features 1, 4
  • Infants <6 months with fever ≥7 days without other explanation should be evaluated for incomplete Kawasaki disease 1, 4
  • Echocardiography is crucial for evaluation of suspected incomplete Kawasaki disease 1, 4

Treatment Protocol

Initial Treatment

  • IVIG: Administer 2 g/kg as a single infusion as early as possible within the first 10 days of fever onset 2, 5
  • Aspirin: High-dose (80-100 mg/kg/day divided into four doses) until the patient is afebrile for 48-72 hours 2, 5
  • After fever resolution, reduce to low-dose aspirin (3-5 mg/kg/day) and continue for 6-8 weeks if no coronary abnormalities are present 2, 6
  • For children who develop coronary abnormalities, aspirin may be continued indefinitely 2

Management of IVIG-Resistant Disease (10-20% of patients)

  • Second dose of IVIG (2 g/kg) for persistent or recrudescent fever 36 hours after initial IVIG infusion 2
  • Consider corticosteroids for patients who remain febrile after two doses of IVIG 2
  • Infliximab (TNF-α inhibitor) is effective in treating IVIG-resistant cases 2

Long-term Management Based on Coronary Involvement

  • No coronary abnormalities: Low-dose aspirin for 6-8 weeks 2
  • Small coronary aneurysms: Long-term low-dose aspirin indefinitely 2
  • Moderate-sized aneurysms (4-6 mm): Aspirin plus a second antiplatelet agent 2
  • Giant aneurysms (≥8 mm): Low-dose aspirin plus warfarin (target INR 2.0-3.0) or aspirin plus therapeutic doses of low-molecular-weight heparin for infants 2

Important Clinical Pearls and Pitfalls

  • Clinical features may not all be present simultaneously; careful history-taking is essential 1
  • The diagnosis can be made with fewer than 5 days of fever if typical clinical findings are present 1
  • Highest risk for coronary artery thrombosis occurs within the first 3 months, with peak incidence in the first 15-45 days 2
  • Delaying treatment beyond 10 days increases the risk of coronary artery abnormalities 2
  • Incomplete Kawasaki disease is more common in children under 1 year, who paradoxically have higher rates of coronary aneurysms if not treated 2
  • Annual influenza vaccination is recommended for children on long-term aspirin therapy 2
  • Measles and varicella immunizations should be deferred for 11 months after high-dose IVIG administration 2
  • Ibuprofen should be avoided in children taking aspirin for its antiplatelet effects 2

References

Guideline

Kawasaki Disease: Definition, Diagnosis, and Clinical Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Kawasaki Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Kawasaki Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of Kawasaki disease.

Clinical pharmacy, 1990

Research

Diagnosis and management of kawasaki disease.

American family physician, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.